-+ 0.00%
-+ 0.00%
-+ 0.00%
CD&R appoints Novartis Chair Giovanni Caforio operating advisor to funds
Share
Listen to the news
CD&R appoints Novartis Chair Giovanni Caforio operating advisor to funds
  • Clayton, Dubilier & Rice named Giovanni Caforio an operating advisor to its funds, focusing on healthcare investment sourcing and evaluation.
  • Caforio is chair of Novartis, leading the board since 2025.
  • He previously spent most of his career at Bristol Myers Squibb, serving as CEO from May 2015 until stepping down in 2023.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Clayton, Dubilier & Rice LLC published the original content used to generate this news brief on September 09, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending